News

Moderna jumps after its updated formulation of Spikevax shows an over 8-fold increase in neutralizing antibodies against the ...
Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) announced clinical trial data to reaffirm the effectiveness and safety of their messenger RNA-based COVID shots on Tuesday after President Donald Trump ...
While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the mRNA COVID vaccine?
Turning to Wall Street, analysts think that Moderna stock has the most room to run. Its price target implies over 96% upside ...
NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
The US Food and Drug Administration (FDA) has approved updated mRNA vaccines from Moderna and Pfizer/BioNTech that protect ...
Dr. Albert Bourla, chairman and CEO of drugmaker Pfizer, says mRNA technology is "extremely well-tested." - Dia Dipasupil/Getty Images Pharmaceutical rivals don’t often come to each other’s defense.
Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...